Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Atrion Corporation

ATRINASDAQ
Healthcare
Medical - Instruments & Supplies
$459.92
$0.26(0.06%)
U.S. Market opens in 15h 46m

Atrion Corporation Fundamental Analysis

Atrion Corporation (ATRI) shows weak financial fundamentals with a PE ratio of 41.72, profit margin of 11.46%, and ROE of 8.05%. The company generates $0.2B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio0.42
Current Ratio9.09

Areas of Concern

ROE8.05%
Cash Position0.77%
We analyze ATRI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 55.8/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
55.8/100

We analyze ATRI's fundamental strength across five key dimensions:

Efficiency Score

Weak

ATRI struggles to generate sufficient returns from assets.

ROA > 10%
7.44%

Valuation Score

Moderate

ATRI shows balanced valuation metrics.

PE < 25
41.72
PEG Ratio < 2
0.42

Growth Score

Moderate

ATRI shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

ATRI maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
9.09

Profitability Score

Weak

ATRI struggles to sustain strong margins.

ROE > 15%
8.05%
Net Margin ≥ 15%
11.46%
Positive Free Cash Flow
No

Key Financial Metrics

Is ATRI Expensive or Cheap?

P/E Ratio

ATRI trades at 41.72 times earnings. This suggests a premium valuation.

41.72

PEG Ratio

When adjusting for growth, ATRI's PEG of 0.42 indicates potential undervaluation.

0.42

Price to Book

The market values Atrion Corporation at 3.33 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.33

EV/EBITDA

Enterprise value stands at 21.57 times EBITDA. This signals the market has high growth expectations.

21.57

How Well Does ATRI Make Money?

Net Profit Margin

For every $100 in sales, Atrion Corporation keeps $11.46 as profit after all expenses.

11.46%

Operating Margin

Core operations generate 13.33 in profit for every $100 in revenue, before interest and taxes.

13.33%

ROE

Management delivers $8.05 in profit for every $100 of shareholder equity.

8.05%

ROA

Atrion Corporation generates $7.44 in profit for every $100 in assets, demonstrating efficient asset deployment.

7.44%

Following the Money - Real Cash Generation

Operating Cash Flow

Atrion Corporation produces operating cash flow of $19.99M, showing steady but balanced cash generation.

$19.99M

Free Cash Flow

Atrion Corporation generates weak or negative free cash flow of $-2.31M, restricting financial flexibility.

$-2.31M

FCF Per Share

Each share generates $-1.31 in free cash annually.

$-1.31

FCF Yield

ATRI converts -0.29% of its market value into free cash.

-0.29%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

41.72

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.42

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.33

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.78

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.001

vs 25 benchmark

Current Ratio

Current assets to current liabilities

9.09

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.08

vs 25 benchmark

ROA

Return on assets percentage

0.07

vs 25 benchmark

ROCE

Return on capital employed

0.09

vs 25 benchmark

How ATRI Stacks Against Its Sector Peers

MetricATRI ValueSector AveragePerformance
P/E Ratio41.7229.43 Worse (Expensive)
ROE8.05%800.00% Weak
Net Margin11.46%-20145.00% (disorted) Strong
Debt/Equity0.000.30 Strong (Low Leverage)
Current Ratio9.094.64 Strong Liquidity
ROA7.44%-17936.00% (disorted) Weak

ATRI outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Atrion Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ